Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Clinical Immunology

Understanding Your Diagnosis: NFKB1-Related Immune Dysregulation

At a Glance

NFKB1-related immune dysregulation is a rare inherited immune condition that can cause frequent infections, autoimmune problems, or no obvious symptoms. Because symptoms may appear at different ages, regular monitoring and genetic counseling can help guide care and family planning.

Receiving a diagnosis of NFKB1-related immune dysregulation can feel like a turning point. For many, it follows years of unexplained infections or health mysteries, providing a name for an invisible struggle [1]. For others, it may be a surprise discovery through family testing. Regardless of how you arrived here, it is normal to feel a mix of relief, anxiety, and uncertainty about the future [2][3].

What is NFKB1-Related Immune Dysregulation?

This condition is a rare inborn error of immunity (IEI)—a group of disorders where a part of the immune system does not develop or function correctly because of a change in your DNA [4]. Specifically, it involves the NFKB1 gene, which provides instructions for making proteins that help control the immune response.

When this gene has a pathogenic mutation (a “variant”), your body may not produce enough of these proteins. This is called haploinsufficiency [5]. Without enough of these proteins, your immune system can become “dysregulated”—it might be too weak to fight off common infections, or it might become overactive and mistakenly attack your own body [6].

How Common Is It?

While the exact number of people in the general population with this condition is not yet known, it is considered rare. Among people already diagnosed with Common Variable Immunodeficiency (CVID), researchers found that approximately 4% to 5% actually have this specific genetic cause [5][7]. Identifying this genetic link allows doctors to move beyond a general CVID label to a more precise understanding of your unique immune system [4].

Understanding Autosomal Dominant Inheritance

You may hear your doctors use the term autosomal dominant to describe how this condition is passed through families. This simply means:

  • Autosomal: The gene is located on one of the numbered chromosomes that both men and women have.
  • Dominant: You only need one copy of the mutated gene (from either parent) to potentially develop the condition [8].

If a person has the NFKB1 variant, there is a 50% (1-in-2) chance of passing that variant to each of their children [8]. However, having the variant does not guarantee that a person will feel sick. This is due to two important concepts: variable penetrance and age-dependent presentation.

The Meaning of “Variable Penetrance”

Not everyone with the NFKB1 variant develops symptoms. This is known as incomplete penetrance. Studies of specific referral cohorts have found that about 70% of people who carry a pathogenic NFKB1 variant develop clinical symptoms, such as frequent infections or autoimmune issues [8][9]. This is a population-level observation, not an individual lifetime prediction.

This means approximately 30% of people with the variant in those cohorts remain “variant-positive individuals without clinical manifestations”—they have the gene change but do not feel sick. However, even these individuals often show subtle changes in their bloodwork, such as different levels of B-cells (the cells that make antibodies), which a specialist can monitor [10][5].

Age and Your Immune System

The presentation of this condition often shows age-related variability, meaning it can become apparent at different times in life [8]. Because the underlying issue can involve subtle early immune changes, some people may have a completely normal childhood and only begin to experience health challenges in their 20s, 30s, or even later [5][11]. This is not always an inevitable progressive struggle, but it does mean your health can change.

Because of this, your medical team will likely recommend regular check-ups even if you feel well. Monitoring your immune “markers” over time helps your doctors catch changes early and decide if or when treatment is needed [11][12].

Navigating the Emotional Impact

Finding out you have a rare genetic condition is a significant life event. It is common to experience:

  • Anxiety and Stress: About 36% of adults in cohorts with similar immune conditions report significant anxiety [2].
  • Diagnostic Fatigue: If you spent years looking for answers, the sudden “end” of that search can be emotionally draining [1].
  • Family Concerns: You might feel worried about relatives or children who could also carry the variant [13].

Your healthcare team is there to support more than just your physical health. Many patients find it helpful to work with a genetic counselor to navigate family conversations or a mental health professional who specializes in chronic or rare conditions [14][13]. Knowing the name of your condition is the first step in building a care plan that is tailored specifically to you.

Common questions in this guide

What does an NFKB1-related immune dysregulation diagnosis mean?
It means a disease-causing change in the NFKB1 gene affects proteins that help control the immune response. The immune system may be less able to fight infections or may become overactive and attack the body’s own tissues. Some people with the variant have few or no noticeable symptoms.
Can I have an NFKB1 variant and never develop symptoms?
Yes. Not everyone who carries a disease-causing NFKB1 variant develops clinical symptoms, a pattern called incomplete penetrance. Some people without noticeable symptoms still have subtle changes in blood tests, so their care team may recommend monitoring.
How is NFKB1-related immune dysregulation passed to children?
It is autosomal dominant, meaning one altered copy of the gene can be enough to cause the condition. A person who carries an NFKB1 variant has a 50% chance of passing it to each child. A child who inherits the variant may or may not develop symptoms.
Why do I need immune checkups if I feel healthy?
Symptoms can first appear in childhood, adulthood, or later, and they are not the same for everyone. Regular visits and blood tests can track immune markers, including B-cell patterns, so clinicians can notice changes early and decide whether treatment or closer follow-up is needed.
Which relatives should consider genetic testing for NFKB1?
Because the condition can be passed through families, biological relatives such as parents, siblings, and children may need a discussion about testing. A genetic counselor or clinician can review the family history, explain the benefits and limits of testing, and identify who should be offered it.
What can B-cell and T-cell tests tell me?
These tests help a specialist assess parts of how the immune system is working. Results are interpreted alongside your infection history, symptoms, and other blood tests; a single result cannot predict exactly whether or when symptoms will develop.
How can genetic counseling help after an NFKB1 diagnosis?
Genetic counseling can explain inheritance, discuss which relatives may consider testing, and support decisions about family planning. A genetic counselor can also help you prepare for conversations with relatives about the diagnosis.

Get notified when new evidence is published on NFKB1-related immune dysregulation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    A qualitative study to explore the burden of disease in activated phosphoinositide 3-kinase delta syndrome (APDS).

    Hitchcock I, Skrobanski H, Matter E, et al.

    Orphanet journal of rare diseases 2024; (19(1)):203 doi:10.1186/s13023-024-03215-9.

    PMID: 38760658
  2. 2

    Anxiety in Polish adult patients with inborn errors of immunity: a cross-sectional study.

    Grochowalska K, Ziętkiewicz M, Nowicka-Sauer K, et al.

    Frontiers in psychiatry 2024; (15()):1293935 doi:10.3389/fpsyt.2024.1293935.

    PMID: 38516260
  3. 3

    Evaluation of Psychiatric Symptomatology, Quality of Life, and Caregiver Burden in Mothers and Children with Primary Immunodeficiency.

    Kılıç N, Kaya Ş, Taşçı G, et al.

    Allergologia et immunopathologia 2023; (51(6)):45-53 doi:10.15586/aei.v51i6.927.

    PMID: 37937495
  4. 4

    Common Variable Immunodeficiency Disorders: A perspective from New Zealand.

    Ameratunga R, J Longhurst H, Lehnert K, et al.

    Clinical reviews in allergy & immunology 2025; (68(1)):105 doi:10.1007/s12016-025-09099-2.

    PMID: 41324804
  5. 5

    Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.

    Tuijnenburg P, Lango Allen H, Burns SO, et al.

    The Journal of allergy and clinical immunology 2018; (142(4)):1285-1296 doi:10.1016/j.jaci.2018.01.039.

    PMID: 29477724
  6. 6

    A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage.

    Fliegauf M, Krüger R, Steiner S, et al.

    Frontiers in immunology 2021; (12()):621503 doi:10.3389/fimmu.2021.621503.

    PMID: 33995346
  7. 7

    A large deletion in a non-coding regulatory region leads to NFKB1 haploinsufficiency in two adult siblings.

    Fusaro M, Coustal C, Barnabei L, et al.

    Clinical immunology (Orlando, Fla.) 2024; (261()):110165 doi:10.1016/j.clim.2024.110165.

    PMID: 38423196
  8. 8

    Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.

    Lorenzini T, Fliegauf M, Klammer N, et al.

    The Journal of allergy and clinical immunology 2020; (146(4)):901-911 doi:10.1016/j.jaci.2019.11.051.

    PMID: 32278790
  9. 9

    Genotype-phenotype analysis in 333 individuals with heterozygous variants in NFKB1.

    Armbruster SM, Caballero-Oteyza A, Bartsch O, et al.

    Journal of human immunity 2027; (3(1)) doi:10.70962/jhi.20260076.

    PMID: 42895832
  10. 10

    Clinical and immunological characterization of NFKB1 haploinsufficiency in Japan.

    Moriya K, Kamiyama Y, Ogino R, et al.

    Frontiers in immunology 2026; (17()):1866459 doi:10.3389/fimmu.2026.1866459.

    PMID: 42488646
  11. 11

    Vulnerability to Meningococcal Disease in Immunodeficiency Due to a Novel Pathogenic Missense Variant in NFKB1.

    Anim M, Sogkas G, Schmidt G, et al.

    Frontiers in immunology 2021; (12()):767188 doi:10.3389/fimmu.2021.767188.

    PMID: 35003082
  12. 12

    Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae.

    Tuovinen EA, Kuismin O, Soikkonen L, et al.

    Clinical immunology (Orlando, Fla.) 2023; (246()):109181 doi:10.1016/j.clim.2022.109181.

    PMID: 36356849
  13. 13

    Genetic Counseling in Pediatric Inborn Errors of Immunity: Perspective Piece on Current Practice and Considerations.

    DeBortoli E, McInerney-Leo A, Macintosh R, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(8)):1918-1927 doi:10.1016/j.jaip.2025.03.052.

    PMID: 40252833
  14. 14

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994

This page is for informational purposes only and does not constitute medical advice. An immunology specialist and genetic counselor can interpret your results and recommend monitoring for your specific situation.